Lesson plan
CD79
The CD79 receptor complex, also known as CD79A:CD79B or Igα:Igβ, is a heterodimeric signaling component of the B-cell receptor (BCR) complex. This transmembrane heterodimer consists of the B-cell antigen receptor complex-associated protein alpha chain (CD79A/Igα) and the B-cell antigen receptor complex-associated protein beta chain (CD79B/Igβ). The CD79 complex is expressed almost exclusively on B cells and B-cell neoplasms, making it valuable for differential diagnosis of B-cell malignancies from T-cell or myeloid neoplasms. CD79a and CD79b are both members of the immunoglobulin superfamily. Human CD79a is encoded by the mb-1 gene that is located on chromosome 19, and CD79b is encoded by the B29 gene that located on chromosome 17. Both CD79 chains contain an immunoreceptor tyrosine-based activation motif (ITAM) in their intracellular tails that they use to propagate a signal in a B cell, in a similar manner to CD3-generated signal transduction observed during T cell receptor activation on T cells.
Article summary
The CD79 receptor complex, also known as CD79A:CD79B or Igα:Igβ, is a heterodimeric signaling component of the B-cell receptor (BCR) complex. This transmembrane heterodimer consists of the B-cell antigen receptor complex-associated protein alpha chain (CD79A/Igα) and the B-cell antigen receptor complex-associated protein beta chain (CD79B/Igβ). The CD79 complex is expressed almost exclusively on B cells and B-cell neoplasms, making it valuable for differential diagnosis of B-cell malignancies from T-cell or myeloid neoplasms. CD79a and CD79b are both members of the immunoglobulin superfamily. Human CD79a is encoded by the mb-1 gene that is located on chromosome 19, and CD79b is encoded by the B29 gene that located on chromosome 17. Both CD79 chains contain an immunoreceptor tyrosine-based activation motif (ITAM) in their intracellular tails that they use to propagate a signal in a B cell, in a similar manner to CD3-generated signal transduction observed during T cell receptor activation on T cells.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.